Evidence map›Paper›PMID 38563595›Full record

ArticleAnalytical chemistry2024

Profiling Intact Glycosphingolipids with Automated Structural Annotation and Quantitation from Human Samples with Nanoflow Liquid Chromatography Mass Spectrometry.

Ryan L Schindler, Armin Oloumi, Jennyfer Tena, Michael Russelle S Alvarez, Yiyun Liu, Sheryl Grijaldo, Mariana Barboza, Lee-Way Jin, Angela M Zivkovic, Carlito B Lebrilla

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ryan L SchindlerDepartment of Chemistry, University of California, Davis, Davis, California 95616, United States.ORCID 0000-0003-4513-7636
Armin OloumiDepartment of Chemistry, University of California, Davis, Davis, California 95616, United States.
Jennyfer TenaDepartment of Chemistry, University of California, Davis, Davis, California 95616, United States.
Michael Russelle S AlvarezDepartment of Chemistry, University of California, Davis, Davis, California 95616, United States.ORCID 0000-0001-6411-9906
Yiyun LiuDepartment of Chemistry, University of California, Davis, Davis, California 95616, United States.ORCID 0009-0001-6941-8611
Sheryl GrijaldoDepartment of Chemistry, University of California, Davis, Davis, California 95616, United States.
Mariana BarbozaInnovation Institute for Food and Health, University of California, Davis, Davis, California 95616, United States.
Lee-Way JinDepartment of Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, California 95817, United States.
Angela M ZivkovicDepartment of Nutrition, University of California, Davis, Davis, California 95616, United States.ORCID 0000-0002-2828-7862
Carlito B LebrillaDepartment of Chemistry, University of California, Davis, Davis, California 95616, United States.ORCID 0000-0001-7190-5323
University of California, Davis · USUniversity of California Davis Medical Center · US

Funding

UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
The incorporation of human milk oligosaccharides in brain glycoconjugatesR01GM049077 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI LEBRILLA, CARLITO B · 1999 to 2024
$6.3M
Comprehensive Characterization of Glycosylation Alterations in Alzheimer’s DiseaseR01AG062240 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JIN, LEE-WAY, LEBRILLA, CARLITO B · 2018 to 2022
$3.3M
Glycomics Equipment: NanoLC CHIP-QTOF Mass SpectrometerS10RR027639 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEBRILLA, CARLITO B · 2010 to 2010
$500k
NCRR NIH HHS S10 RR027639NIA NIH HHS P30 AG072972NIA NIH HHS R01 AG062240NIGMS NIH HHS R01 GM049077
6 · The paper itself

Abstract

Sphingolipids are an essential subset of bioactive lipids found in most eukaryotic cells that contribute to membrane biophysical properties and are involved in cellular differentiation, recognition, and mediating interactions. The described nanoHPLC-ESI-Q/ToF methodology utilizes known biosynthetic pathways, accurate mass detection, optimized collision-induced disassociation, and a robust nanoflow chromatographic separation for the analysis of intact sphingolipids found in human tissue, cells, and serum. The methodology was developed and validated with an emphasis on addressing the common issues experienced in profiling these amphipathic lipids, which are part of the glycocalyx and lipidome. The high sensitivity obtained using nanorange flow rates with robust chromatographic reproducibility over a wide range of concentrations and injection volumes results in confident identifications for profiling these low-abundant biomolecules.

Indexed as

GlycosphingolipidsLiquid Chromatography-Mass SpectrometryChromatography, High Pressure LiquidChromatography, LiquidHumansReproducibility of ResultsSphingolipidsGlycosphingolipidsSphingolipids

Identifiers

PMID38563595
PMCPMC11024888
OpenAlexW4393536580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.